Results 271 to 280 of about 21,694,421 (382)
The pan‐HDAC inhibitor belinostat increases the expression of the pro‐apoptotic proteins Bim, Puma, and Noxa and induces apoptosis in ovarian cancer cell lines and patient‐derived tumor organoids when used at high concentrations. Moreover, inhibiting the anti‐apoptotic proteins Bcl‐xL or Mcl‐1 sensitizes these preclinical models to the cytotoxic effect
Cécilia Thomine+10 more
wiley +1 more source
A computational cognitive neuroscience approach for characterizing individual differences in autism: Introduction to Special Issue. [PDF]
Liu W+3 more
europepmc +1 more source
Individual Differences in Mode of Processing in Visual Asymmetry Tasks
Anke Bouma, Martin J. Ippel
openalex +1 more source
Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer
Fibroblasts, cells in the tumor environment, support ovarian cancer cell growth and alter morphology and drug response. We used fibroblast and cancer cell co‐culture models to test 528 drugs and discovered new drugs for combination treatment. We showed that adding Vorinostat or Birinapant to standard chemotherapy may improve drug response, suggesting ...
Greta Gudoityte+10 more
wiley +1 more source
Introduction to the Special Issue "Personality and Individual Differences". [PDF]
Brauer K, Proyer RT.
europepmc +1 more source
Individual differences in the functional asymmetry of the human brain
Anna Grabowska+4 more
openalex +2 more sources
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song+11 more
wiley +1 more source
Individual Differences in Placebo Analgesia: Functional Connectivity and Neural Mechanisms [Letter]. [PDF]
Cao H, Zhang Y, Bai L, Ma X.
europepmc +1 more source